Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Jul 9;93(14):7149–7153. doi: 10.1073/pnas.93.14.7149

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

C De Smet 1, O De Backer 1, I Faraoni 1, C Lurquin 1, F Brasseur 1, T Boon 1
PMCID: PMC38951  PMID: 8692960

Abstract

Human gene MAGE-1 encodes tumor-specific antigens that are recognized on melanoma cells by autologous cytolytic T lymphocytes. This gene is expressed in a significant proportion of tumors of various histological types, but not in normal tissues except male germ-line cells. We reported previously that reporter genes driven by the MAGE-1 promoter are active not only in the tumor cell lines that express MAGE-1 but also in those that do not. This suggests that the critical factor causing the activation of MAGE-1 in certain tumors is not the presence of the appropriate transcription factors. The two major MAGE-1 promoter elements have an Ets binding site, which contains a CpG dinucleotide. We report here that these CpG are demethylated in the tumor cell lines that express MAGE-1, and are methylated in those that do not express the gene. Methylation of these CpG inhibits the binding of transcription factors, as seen by mobility shift assay. Treatment with the demethylating agent 5-aza-2'-deoxycytidine activated gene MAGE-1 not only in tumor cell lines but also in primary fibroblasts. Finally, the overall level of CpG methylation was evaluated in 20 different tumor cell lines. It was inversely correlated with the expression of MAGE-1. We conclude that the activation of MAGE-1 in cancer cells is due to the demethylation of the promoter. This appears to be a consequence of a genome-wide demethylation process that occurs in many cancers and is correlated with tumor progression.

Full text

PDF
7149

Images in this article

7150Fig. 1
on p.7150
7151Fig. 2
on p.7151
7152Fig. 3
on p.7152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedford M. T., van Helden P. D. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res. 1987 Oct 15;47(20):5274–5276. [PubMed] [Google Scholar]
  2. Bentley N. J., Eisen T., Goding C. R. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol. 1994 Dec;14(12):7996–8006. doi: 10.1128/mcb.14.12.7996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bird A. The essentials of DNA methylation. Cell. 1992 Jul 10;70(1):5–8. doi: 10.1016/0092-8674(92)90526-i. [DOI] [PubMed] [Google Scholar]
  4. Blin N., Stafford D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 1976 Sep;3(9):2303–2308. doi: 10.1093/nar/3.9.2303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boon T., Cerottini J. C., Van den Eynde B., van der Bruggen P., Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337–365. doi: 10.1146/annurev.iy.12.040194.002005. [DOI] [PubMed] [Google Scholar]
  6. Boël P., Wildmann C., Sensi M. L., Brasseur R., Renauld J. C., Coulie P., Boon T., van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 1995 Feb;2(2):167–175. doi: 10.1016/s1074-7613(95)80053-0. [DOI] [PubMed] [Google Scholar]
  7. Brasseur F., Marchand M., Vanwijck R., Hérin M., Lethé B., Chomez P., Boon T. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer. 1992 Nov 11;52(5):839–841. doi: 10.1002/ijc.2910520528. [DOI] [PubMed] [Google Scholar]
  8. Brasseur F., Rimoldi D., Liénard D., Lethé B., Carrel S., Arienti F., Suter L., Vanwijck R., Bourlond A., Humblet Y. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer. 1995 Nov 3;63(3):375–380. doi: 10.1002/ijc.2910630313. [DOI] [PubMed] [Google Scholar]
  9. Chambost H., Brasseur F., Coulie P., de Plaen E., Stoppa A. M., Baume D., Mannoni P., Boon T., Maraninchi D., Olive D. A tumour-associated antigen expression in human haematological malignancies. Br J Haematol. 1993 Jul;84(3):524–526. doi: 10.1111/j.1365-2141.1993.tb03111.x. [DOI] [PubMed] [Google Scholar]
  10. Chomez P., Williams R., De Backer O., Boon T., Vennström B. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics. 1996;43(1-2):97–100. doi: 10.1007/BF00186613. [DOI] [PubMed] [Google Scholar]
  11. De Plaen E., Arden K., Traversari C., Gaforio J. J., Szikora J. P., De Smet C., Brasseur F., van der Bruggen P., Lethé B., Lurquin C. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994;40(5):360–369. doi: 10.1007/BF01246677. [DOI] [PubMed] [Google Scholar]
  12. De Smet C., Courtois S. J., Faraoni I., Lurquin C., Szikora J. P., De Backer O., Boon T. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics. 1995;42(4):282–290. doi: 10.1007/BF00176446. [DOI] [PubMed] [Google Scholar]
  13. De Smet C., Lurquin C., van der Bruggen P., De Plaen E., Brasseur F., Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics. 1994;39(2):121–129. doi: 10.1007/BF00188615. [DOI] [PubMed] [Google Scholar]
  14. Diala E. S., Cheah M. S., Rowitch D., Hoffman R. M. Extent of DNA methylation in human tumor cells. J Natl Cancer Inst. 1983 Oct;71(4):755–764. [PubMed] [Google Scholar]
  15. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eden S., Cedar H. Role of DNA methylation in the regulation of transcription. Curr Opin Genet Dev. 1994 Apr;4(2):255–259. doi: 10.1016/s0959-437x(05)80052-8. [DOI] [PubMed] [Google Scholar]
  17. Feinberg A. P., Gehrke C. W., Kuo K. C., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988 Mar 1;48(5):1159–1161. [PubMed] [Google Scholar]
  18. Feinberg A. P., Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun. 1983 Feb 28;111(1):47–54. doi: 10.1016/s0006-291x(83)80115-6. [DOI] [PubMed] [Google Scholar]
  19. Frost P., Liteplo R. G., Donaghue T. P., Kerbel R. S. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine. J Exp Med. 1984 May 1;159(5):1491–1501. doi: 10.1084/jem.159.5.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gama-Sosa M. A., Slagel V. A., Trewyn R. W., Oxenhandler R., Kuo K. C., Gehrke C. W., Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 1983 Oct 11;11(19):6883–6894. doi: 10.1093/nar/11.19.6883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gaugler B., Van den Eynde B., van der Bruggen P., Romero P., Gaforio J. J., De Plaen E., Lethé B., Brasseur F., Boon T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994 Mar 1;179(3):921–930. doi: 10.1084/jem.179.3.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jassim A., Ollier W., Payne A., Biro A., Oliver R. T., Festenstein H. Analysis of HLA antigens on germ cells in human semen. Eur J Immunol. 1989 Jul;19(7):1215–1220. doi: 10.1002/eji.1830190710. [DOI] [PubMed] [Google Scholar]
  23. Liteplo R. G., Kerbel R. S. Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma cell line MeWo. Cancer Res. 1987 May 1;47(9):2264–2267. [PubMed] [Google Scholar]
  24. Muscatelli F., Walker A. P., De Plaen E., Stafford A. N., Monaco A. P. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4987–4991. doi: 10.1073/pnas.92.11.4987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pfeifer G. P., Steigerwald S., Boehm T. L., Drahovsky D. DNA methylation levels in acute human leukemia. Cancer Lett. 1988 Mar;39(2):185–192. doi: 10.1016/0304-3835(88)90103-6. [DOI] [PubMed] [Google Scholar]
  26. Rocamora N., Mezquita C. Chicken spermatogenesis is accompanied by a genomic-wide loss of DNA methylation. FEBS Lett. 1989 Apr 24;247(2):415–418. doi: 10.1016/0014-5793(89)81382-1. [DOI] [PubMed] [Google Scholar]
  27. Rogner U. C., Wilke K., Steck E., Korn B., Poustka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics. 1995 Oct 10;29(3):725–731. doi: 10.1006/geno.1995.9945. [DOI] [PubMed] [Google Scholar]
  28. Singer-Sam J., Grant M., LeBon J. M., Okuyama K., Chapman V., Monk M., Riggs A. D. Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol. 1990 Sep;10(9):4987–4989. doi: 10.1128/mcb.10.9.4987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takahashi K., Shichijo S., Noguchi M., Hirohata M., Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 1995 Aug 15;55(16):3478–3482. [PubMed] [Google Scholar]
  30. Van den Eynde B., Peeters O., De Backer O., Gaugler B., Lucas S., Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med. 1995 Sep 1;182(3):689–698. doi: 10.1084/jem.182.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weber J., Salgaller M., Samid D., Johnson B., Herlyn M., Lassam N., Treisman J., Rosenberg S. A. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer Res. 1994 Apr 1;54(7):1766–1771. [PubMed] [Google Scholar]
  32. Weynants P., Lethé B., Brasseur F., Marchand M., Boon T. Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer. 1994 Mar 15;56(6):826–829. doi: 10.1002/ijc.2910560612. [DOI] [PubMed] [Google Scholar]
  33. Wilson V. L., Jones P. A. DNA methylation decreases in aging but not in immortal cells. Science. 1983 Jun 3;220(4601):1055–1057. doi: 10.1126/science.6844925. [DOI] [PubMed] [Google Scholar]
  34. del Mazo J., Prantera G., Torres M., Ferraro M. DNA methylation changes during mouse spermatogenesis. Chromosome Res. 1994 Mar;2(2):147–152. doi: 10.1007/BF01553493. [DOI] [PubMed] [Google Scholar]
  35. van der Bruggen P., Szikora J. P., Boël P., Wildmann C., Somville M., Sensi M., Boon T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol. 1994 Sep;24(9):2134–2140. doi: 10.1002/eji.1830240930. [DOI] [PubMed] [Google Scholar]
  36. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991 Dec 13;254(5038):1643–1647. doi: 10.1126/science.1840703. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES